Arquivamento definitivo - Art. 33 da LPI
#11.1.1
09/03/2024
RPI 2800
Application data
Number
112021023814Type
Filing
Publication
PCT
US2021036638 The application was abandoned: examination was not requested within the 36 months following the 06/09/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 09/03/2024. We update with every new RPI gazette, published weekly.
Applicants
PARDES BIOSCIENCES, INC.
US
Inventors
A. J. (pessoa física)
US
L. A. (pessoa física)
US
W. K. (pessoa física)
US
IPC Classification
Priority claims
US
63/036,866 · 06/09/2020
US
63/039,297 · 06/15/2020
US
63/067,669 · 08/19/2020
US
63/091,630 · 10/14/2020
US
63/129,018 · 12/22/2020
US
63/171,675 · 04/07/2021
US
63/172,478 · 04/08/2021
US
63/173,146 · 04/09/2021
US
63/179,128 · 04/23/2021
US
63/195,460 · 06/01/2021
Abstract
A invenção fornece compostos com grupos reativos e seu uso no tratamento de doenças ou distúrbios médicos, tais como infecções virais. São fornecidas composições farmacêuticas e métodos de fabricação de vários compostos com grupos reativos. Os compostos são contemplados para inibir proteases, tais como a protease semelhante a 3C, CL- ou 3CL.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
09/03/2024
RPI 2800
#11.1
06/18/2024
RPI 2789
#1.3
12/20/2022
RPI 2711
#1.1
02/01/2022
RPI 2665
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.